Total Funding
52
Total FundingPost-IPO Equity raised
Growth Score
pts
Heat Score
6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
89776
Heska develops medical devices to improve the quality of pet care and to ensure positive outcomes for veterinarians and their patients.
Michael J. McGinley: President, Biologicals and Pharmaceuticals- Nancy Wisnewski: Executive Vice President and Chief Operating OfficerPast Role: HESKA, Executive Vice President, Diagnostic Operations and Product Development
About the Company
Heska Corporation manufactures, develops and sells advanced veterinary diagnostic and specialty healthcare products through its two business segments: North America and International. Both segments include Point of Care Lab testing instruments and consumables, digital imaging products, software and services, data services, allergy testing and
immunotherapy, and single-use offerings such as in-clinic diagnostic tests and heartworm preventive products. The North America segment also includes private label vaccine and pharmaceutical production under third-party agreements and channels, primarily for herd animal health.
Women Founded
